Simeon Kohl bought $105k of HCAT
Chief Executive Officer at Health Catalyst, Inc.. 59,000 shares at an average of $1.79, traded Sep 14, 2026, filed Sep 16, 2026.
Score components
- +25RoleCEO
- +10Trade size$105k at market
- 0Relative to holdingsHoldings up 2.1%
- +8Price context47% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001703807-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | AGrant or award Common Stock | +2,747,385 | $0.00 | $0 | 2,797,385 | 27 d ago |
| Sep 14, 2026 | POpen-market purchase Common Stock | +59,000 | $1.79 | $105k | 2,856,385 | 27 d ago |
Related signals
Other insiders at Health Catalyst, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | Health Catalyst, Inc. | Julie Larson-Green director | $128k 47,997 shares | -39% | |
| 16Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $72k 27,425 shares | -22% | |
| 0Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $21k 6,175 shares | -4% | |
| 0Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $24k 6,057 shares | -4% | |
| 0Weak | Health Catalyst, Inc. | Daniel LeSueur Chief Operating Officer | $21k 5,209 shares | -2% | |
| 0Weak | Health Catalyst, Inc. | Daniel LeSueur Chief Operating Officer | $22k 5,209 shares | -2% | |
| 16Weak | Health Catalyst, Inc. | Daniel LeSueur Chief Operating Officer | $76k 16,902 shares | -7% | |
| 11Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $63k 13,827 shares | -8% | |
| 9Weak | Health Catalyst, Inc. | Linda Llewelyn Chief People Officer | $35k 6,441 shares | -7% | |
| 13Weak | Health Catalyst, Inc. | Daniel LeSueur Chief Operating Officer | $30k 5,209 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.